CAVERS GREG (Chief Financial Officer) purchased 3K shares of HELUS PHARMA INC. on the open market
Open‑market purchase worth $38.7K. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 10/2/2026ACC: 0000912282-26-001334
Officer· Chief Financial Officer
Since Sep 2026
+3K
Net shares
Net buyer
$38.7K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
3K acquired
Non-Derivative Transactions1
Common Shares
Indirect
Shares
+3K
Price / share
$12.91
Trade value
$38.73K
% of position
New position
9/29/2026
0.00→3K
Total
Net shares
+3K
Net value
$38.73K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Indirect | 9/29/2026 | P · Purchase | +3K | $12.91 | $38.73K | New position | 0.00 | 3K |
| Total | +3K | $38.73K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Shares
DirectShares owned125.94K
Total
125.94K direct125.94K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Shares | 125.94K | Direct |
| Total | 125.94K | 125.94K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported